ReviewCancer immunology, immunotherapy : CII2023
TIM-3 as a promising target for cancer immunotherapy in a wide range of tumors.
Natalia Sauer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
94 papers cite itlatest 60 shown
this paperpooled itcites it